He was already scheduled for a surveillance chest CT the day prior to admission.
The chest CT performed [**2171-7-22**] revealed several new lung nodules as well as a moderate right pleural effusion.
In the oncology clinic today, he was found to have a respiratory rate in the 40s with an O2 sat of 91%.
Physical Exam: EXAM ON TRANSFER FROM MICU TO FLOOR: T99.8, HR 93, 110/63, R36, 95% on FiO2 0.6 (now on 6L NC) Alert, awake, appropriate.
Extrem warm, [**12-16**]+ LE edema, no sacral edema.
Pertinent Results: ADMISSION LABS: [**2171-7-23**] 01:20PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.026 [**2171-7-23**] 01:20PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG [**2171-7-23**] 01:20PM URINE  RBC-3* WBC-1 BACTERIA-FEW YEAST-NONE EPI-0 [**2171-7-23**] 01:20PM URINE  GRANULAR-3* HYALINE-1* [**2171-7-23**] 01:20PM URINE  MUCOUS-RARE [**2171-7-23**] 11:55AM   LACTATE-1.7 [**2171-7-23**] 11:45AM   GLUCOSE-158* UREA N-25* CREAT-1.2 SODIUM-136 POTASSIUM-4.9 CHLORIDE-101 TOTAL CO2-27 ANION GAP-13 [**2171-7-23**] 11:45AM   cTropnT-<0.01 [**2171-7-23**] 11:45AM   ALBUMIN-3.0* [**2171-7-23**] 11:45AM   WBC-13.2* RBC-2.99* HGB-8.3* HCT-27.1* MCV-91 MCH-27.7 MCHC-30.6* RDW-18.1* [**2171-7-23**] 11:45AM   NEUTS-83.8* LYMPHS-9.0* MONOS-5.4 EOS-1.2 BASOS-0.6 [**2171-7-23**] 11:45AM   PLT COUNT-815* [**2171-7-23**] 11:45AM   PT-14.9* PTT-50.8* INR(PT)-1.3*  Labs on transfer: [**2171-7-25**] 03:55AM BLOOD WBC-11.5* RBC-2.59* Hgb-7.2* Hct-23.3* MCV-90 MCH-27.8 MCHC-31.0 RDW-17.7* Plt Ct-626* [**2171-7-25**] 03:55AM BLOOD PT-14.7* PTT-39.3* INR(PT)-1.3* [**2171-7-25**] 03:55AM BLOOD Glucose-134* UreaN-26* Creat-1.0 Na-137 K-4.5 Cl-101 HCO3-28 AnGap-13 [**2171-7-25**] 03:55AM BLOOD TotProt-5.8* Calcium-8.2* Phos-3.6 Mg-2.1 BNP 583 .
[**2171-7-22**] CT C/A/P: IMPRESSION: 1.
The opacities in the right lower lung, associated to a mild-to-moderate pleural effusion, are unchanged in extent.
CTA chest showed no evidence of a PE and a cardiac echo showed no evidence of heart failure.
Broadened coverage for bacterial pneumonia with ceftriaxone ([**2171-7-26**]) and azithromycin ([**2171-7-25**])followed by vanco and zosyn, without significant clinical benefit.CTA negative for PE and cardiac echo without evidence of heart failure.
Medications on Admission: ATORVASTATIN [LIPITOR] 20 mg Tablet - 1 Tablet(s) by mouth at bedtime BIMATOPROST [LUMIGAN] - 0.01 % Drops - 1 drop(s) both eyes at bedtime DOXAZOSIN - 4 mg Tablet - one and half Tablet(s) by mouth daily ENOXAPARIN - 80 mg/0.8 mL Syringe subcutaneous every twelve (12) hours FUROSEMIDE 20 mg Tablet by mouth once a day MULTIVITAMIN one Tablet(s) by mouth daily  Discharge Medications: 1. senna 8.6 mg Capsule Sig: One (1) Tablet PO BID (2 times a day) as needed for Constipation.
Disp:*30 Tablet(s)* Refills:*0* 2. docusate sodium 50 mg/5 mL Liquid Sig: [**4-23**] ml PO BID (2 times a day) as needed for constipation.
Disp:*30 Tablet(s)* Refills:*0* 4. enoxaparin 80 mg/0.8 mL Syringe Sig: Eighty (80) Subcutaneous Q12H (every 12 hours).
A chest CT-angio was negative for a pulmonary emboli ( lung clot) and an echocardiogram showed good heart function.
